Journal Pre-proof J o u r n a l P r e -p r o o f Abstract Itch is a somatosensory sensation that informs the organism about the presence of potentially harmful substances or parasites, and initiates scratching to remove the threat. Itch-inducing (pruritogenic) substances activate primary afferent neurons in the skin through interactions with specific receptors that converts the stimulus into an electrical signal. These signals are conveyed to the dorsal horn of the spinal cord through the release of neurotransmitters such as natriuretic polypeptide b and somatostatin, leading to an integrated response within a complex spinal interneuronal network. A large sub-population of somatostatin-expressing spinal interneurons also carry the Neuropeptide Y (NPY) Y1 receptor, indicating that NPY and somatostatin partly regulate the same neuronal pathway. This review focuses on recent findings regarding the role of the NPY/Y1 and somatostatin/SST 2A receptor in itch, and also presents data integrating the two neurotransmitter systems. Journal Pre-proof GRPR neurons, and induce a scratching behavior, through bursts of action potentials, showing that persistent activation of GRP/GRPR neurons are needed to evoke itch (Pagani et al., 2019). Until recently, it was not known if GRPR neurons were interneurons, relaying the itch signal within the spinal cord or if they were projection neurons, sending information directly to the Journal Pre-proof We acknowledge Elín Magnúsdóttir for proofreading and Bradley Taylor and Tyler Nelson for valuable input to the manuscript. This work was supported by grants from the Swedish Research Council, Uppsala University, The Brain foundation and the foundations of Ragnar Söderberg and Byggmästare Olle Engkvist. MCL is a Ragnar Söderberg Fellow in Medicine. The authors declare no conflict of interest. Journal Pre-proof J o u r n a l P r e -p r o o f Highlights  The review covers current knowledge regarding the role of Neuropeptide Y in itch regulation  The analysis shows that the Y1 antagonist BIBO3304 increase scratching behavior induced by the somatostatin agonist octreotide Journal Pre-proof
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The excitatory itch-pathway
In 2007, Sun and Chen identified neurons expressing the Gastrin releasing peptide receptor (GRPR) to be critical for itch transmission through the spinal cord (Sun and Chen, 2007) . Grpr -/- mice, or mice with ablated GRPR neurons, exhibit normal responses to pain and temperature stimuli, whilst showing markedly decreased scratching responses towards both histaminergic and non-histaminergic pruritogens (Sun and Chen, 2007; Sun et al., 2009) , and intrathecal injection of a GRPR antagonist inhibits pruritogen-induced scratch responses as well (Sun and Chen, 2007) .
Conditional knockout of the vesicular glutamate transporter 2 (Vglut2) in Grpr-Cre neurons markedly decreases responses towards both histaminergic and non-histaminergic pruritogens, indicating that the itch transmission is dependent on glutamate (Aresh et al., 2017) . Initially, Sun and Chen detected GRP in small DRG primary afferents, and suggested that these are the source of the GRP that activates GRPR neurons in response to itch stimuli (Sun and Chen, 2007) . Later, the neuropeptide natriuretic polypeptide b (Nppb/BNP), which is expressed in a subset of DRG primary afferents, was shown to be critical for itch signaling (Mishra and Hoon, 2013) . Nppb -/mice show drastically reduced responses to both histaminergic and non-histaminergic pruritic stimuli, while retaining normal temperature and proprioception phenotypes (Mishra and Hoon, 2013) . Cells expressing the receptor for BNP, namely NPR1 (natriuretic peptide receptor 1), express GRP in the dorsal horn of the spinal cord and induce itch in a GRP-dependent manner when activated by intrathecal injection of BNP, further supporting the role of BNP in itch transmission (Mishra and Hoon, 2013) . Lately, spinal GRP neurons were shown to activate J o u r n a l P r e -p r o o f brain. However, very few Grpr-Cre neurons are labelled when retrogradely traced from the lateral parabrachial area (LpB) or thalamus (Aresh et al., 2017) . Optogenetic activation of Grpr-Cre neurons induces activation of parabrachial projection neurons with a short latency indicative of a monosynaptic connection (Mu et al., 2017) . An AMPA receptor antagonist could block this activation, providing support that GRPR neurons signal directly to projection neurons using glutamate (Mu et al., 2017) . Hence, spinal GRPR neurons represent excitatory interneurons that contact pruriceptive projection neurons.
Unlocking the itch gate with somatostatin
Inhibitory neurons transiently expressing the transcription factor Bhlhb5 during development (B5-I neurons) play a critical role in the inhibition of chemical itch (Kardon et al., 2014; Ross et al., 2010) . These neurons also express the neuropeptide dynorphin, which is postulated to inhibit GRP-induced itch either at the level of GRPR neurons or downstream of them, via the kappa opioid receptor (Huang et al., 2018; Kardon et al., 2014) (Figure 1A ). B5-I neurons also express the inhibitory somatostatin (SST) receptor SST 2A , and intrathecal injection of the SST 2A agonist octreotide increases the scratch response elicited by a subcutaneous chloroquine (CQ) injection (Kardon et al., 2014) , indicating that activation of the inhibitory receptor SST 2A removes the proposed inhibitory tone exerted on the itch pathway by the B5-I neurons (disinhibition).
Intrathecal injection of SST or SST 2A agonists potentiate itch (Huang et al., 2018; Kardon et al., 2014) , so determination of the source of SST in vivo is of great interest. Sst is expressed in Nppbpositive primary afferents and in several populations of excitatory interneurons in the dorsal horn of the spinal cord, including around 66% of the Neuropeptide Y (NPY) Y1 receptor-expressing neurons and around 92% of Grp positive neurons (Haring et al., 2018; Huang et al., 2018;  J o u r n a l P r e -p r o o f Usoskin et al., 2015; Zhang et al., 1999) (Figure 1A-B ). Interestingly, only mice lacking SST in both primary afferents and in spinal interneurons show decreased scratch responses to histaminergic and non-histaminergic pruritogens (Huang et al., 2018) , indicating that activity in SST-expressing pruriceptive primary afferent neurons can compensate for the loss of SST in excitatory interneurons, and vice versa. Spinal SST neurons have also been associated with mechanical (Duan et al., 2014) and neuropathic (Nelson et al., 2019) pain transduction.
Role of NPY neurons in itch
Spinal NPY neurons are located throughout lamina I-IV in the dorsal horn of the spinal cord (Bourane et al., 2015; Polgar et al., 2013) . They are almost exclusively inhibitory (Bourane et al., 2015; Polgar et al., 2011) and do not overlap with the B5-I population (Kardon et al., 2014) ( Figure 1A ). Rabies viral tracing has revealed that input to NPY neurons includes low threshold mechanoreceptors and dorsal root stimulation revealed mono-synaptic or polysynaptic input from Aβ, Aδ and C-fiber afferents, indicating that NPY neurons integrate innocuous mechanical and pain transmission (Bourane et al., 2015) . Also, modalities such as noxious heat, noxious mechanical stimuli and tissue injury-induced pain are suggested to give input to NPY neurons; for example: 1) capsaicin injected in the hind paw of mice gives rise to VGLUT2-dependent c-Fos signals in NPY neurons in the spinal cord (Liu et al., 2010) ; and 2) capsaicin, formalin or noxious mechanical stimuli (pinch) increase the expression of phosphorylated ERK (pERK) in NPY neurons (Polgar et al., 2013) ; and 3) TRPV1 (the receptor for capsaicin) activation induces dorsal horn NPY release as measured by agonist-induced receptor-mediated internalization of Y1 (Marvizon et al., 2019) ( Figure 1A ). The output from NPY neurons has been investigated by analyzing the location of NPY-filled boutons; with this method NPY neurons have so far been shown to terminate on lamina III projection neurons expressing the Neurokinin 1 receptor J o u r n a l P r e -p r o o f (NK1R) (Polgar et al., 2011; Polgar et al., 1999) and on the excitatory interneurons in lamina II expressing PKCγ (Polgar et al., 2011) .
Two members of the NPY receptor family are definitively expressed in the spinal cord network (Naveilhan et al., 1998) . NPY receptor 1 (Y1) is expressed in 19% of SST-positive excitatory interneurons, and in 21% of GRP-expressing interneurons in the dorsal horn, as well as in some DRG neurons (Haring et al., 2018; Naveilhan et al., 1998; Zhang et al., 1999 ) ( Figure 1B ). NPY receptor 2 (Y2) is mostly expressed in DRG neurons and is present on central presynaptic terminals (Brumovsky et al., 2005; Usoskin et al., 2015) . Both Y1 and Y2 are G protein-coupled receptors that associate with G i/o proteins, so activation of the NPY-receptor system inactivates adenylyl cyclase activity, which results in reduced cAMP synthesis. NPY-induced activation of G protein complexes can also inhibit Ca 2+ channels and enhance G protein-coupled inwardly rectifying potassium channel (GIRK) currents, which subsequently induce hyperpolarization of neurons (Acuna-Goycolea et al., 2005; Persaud and Bewick, 2014) .
Previously, NPY has been a focus of pain research, and the results have been divergent, as different groups have found pro-nociceptive and anti-nociceptive effects (Brumovsky et al., 2007) . This difference seems to be dependent on the route of delivery of NPY. Subcutaneous administration of NPY in mice with a partially transected sciatic nerve increases mechanical and thermal hyperalgesia (Tracey et al., 1995) , whereas intrathecal administration reduces mechanical allodynia and hyperalgesia following spared nerve injury (SNI) (Intondi et al., 2008) . Recently, NPY was shown to affect itch transmission as well. Selective ablation of spinal NPY neurons induces spontaneous scratching in mice (Bourane et al., 2015) . However, these mice demonstrate normal responses to chemically induced itch, as they do not differ from controls in the number of J o u r n a l P r e -p r o o f scratch episodes evoked by the mast cell degranulator compound 48/80 or CQ injected in the back of the neck, but they do show a marked increase in scratch responses to mechanical itch induced by 0.07g von Frey hairs against the nape of the neck (Bourane et al., 2015) . This response is not inhibited by the ablation of GRPR neurons, demonstrating that the effect of NPY on mechanical itch is not dependent on the GRP-GRPR pathway (Bourane et al., 2015) . Recently, we could confirm the mechanical itch phenotype and associate it with the NPY/Y1 system by injecting the selective Y1 receptor agonist LP-NPY intrathecally before mechanical itch was provoked using 0.07 g von Frey filaments (Gao et al., 2018) . We could further demonstrate that the duration of scratch episodes induced by compound 48/80 and histamine was decreased, whereas the frequency of the episodes was unchanged (Gao et al., 2018) . The difference in (Acton et al., 2019) . Here the authors showed that ablating Y1-expressing neurons in the spinal cord overturns the spontaneous scratch phenotype observed in NPY neuron-ablated mice (Bourane et al., 2015) and that Npy1r conditional knockouts display an increased scratch behavior upon von Frey stimulation. The Npy1r conditional knockouts did, however, not display an altered scratch behavior towards the chemical itch stimuli tested (Acton et al., 2019) . Our previous analysis shows that intrathecal injection of the Y1 antagonist BIBO3304 does not alter the duration, frequency or mean length of scratch episodes of compound 48/80-evoked scratch behavior compared to saline injection, which is consistent with the data obtained from the Npy1r conditional knockouts. However, when we sub-analyzed the distribution of scratch episode J o u r n a l P r e -p r o o f duration, we could detect that there was a facilitation in certain intervals in Y1 antagonist-treated animals compared with controls (Gao et al., 2018) . In conclusion, the NPY-Y1 system inhibits both mechanical and chemical itch.
Recently, the urocortin 3 (UCN3) population of excitatory interneurons was associated with mechanical itch as UCN3 neuron-ablated mice showed decreased scratching behavior after application of light mechanical stimuli (von Frey hairs), whereas the number of scratch episodes induced by chemical pruritogens was not affected, except histamine-induced alloknesis (Pan et al., 2019) . ScRNAseq based bioinformatical analysis shows that 100% of Ucn3 neurons coexpress Sst and 28% of Ucn3 neurons express Npy1r ( Figure 1B) (Haring et al., 2018) , which indicates that a sub-population of Y1/SST/UCN3 neurons might be dedicated to the transmission of mechanical itch, whereas the remaining Y1 neurons are involved in other modalities such as pain and/or chemical itch transmission ( Figure 1A) . Grpr and Ucn3 mRNA are rarely coexpressed (4-6%, (Haring et al., 2018) ) ( Figure 1B) , which together with recent behavioral analysis described in this review suggest that these two populations might represent two distinct portals in the spinal cord; one for chemical and one for mechanical itch, respectively.
To further address the relationship between the somatostatin pathway and the NPY-Y1 system in the spinal cord, we performed intrathecal pre-treatment with the Y1 antagonist BIBO3304 10 minutes before the SST 2A agonist octreotide was delivered through the same route. Compared to saline pre-treated mice, the scratch duration was significantly increased when the Y1 antagonist BIBO3304 was administered prior to the octreotide injection (P=0.0462) ( Figure 1C ). The number of scratch episodes (P=0.4786) or mean length of scratch episodes (P=0.0596) were not significantly altered compared to the saline-treated group (Figure 1D-E) . Our present data thus J o u r n a l P r e -p r o o f show that octreotide-induced scratching behavior through the SST 2A receptor can be facilitated by blocking Y1, implying that endogenous NPY, released by the counter-stimuli (Marvizon et al., 2019; Polgar et al., 2013) , cannot dampen the scratching behavior as efficiently as in salinetreated mice ( Figure 1A) . The Y1 antagonist can theoretically act on several sites in the spinal itch circuitry; including populations expressing SST, UCN3 and/or GRP (Haring et al., 2018) ( Figure 1A-B ), thereby directly affecting neurons belonging to the GRP/GRPR pathway, neurons associated with the disinhibition process of chemical itch and neurons conveying mechanical itch.
In conclusion, somatostatin drives the scratching response most likely by reducing an inhibitory tone exerted on the spinal itch pathway (Huang et al., 2018; Kardon et al., 2014) . NPY dampens both mechanically and chemically induced scratching and our results summarized here indicate that one possible mechanism is through Y1-mediated inhibition of pathways involving SSTexpressing interneurons. a controlled environment at 20 to 24°C, 45% to 65% humidity, and during the light 12-hour day/night cycle. Adult male C57BL6 mice (>7 weeks old) were placed and acclimated for 5-10 minutes in a transparent plastic chamber (820 cm 3 ) with bedding before they were sedated using isoflurane and injected intrathecally with 5 μL of 100 nM BIBO3304 (BIBO3304 trifluoroacetate salt, 0.38 ng/5 μL, Tocris Bioscience, Bristol, UK), 10 minutes before 5 μL of 3.92 µM octreotide (octreotide acetate, 20 ng/5 μL, Bachem, Bubendorf, Switzerland) was injected through the same route. The scratching behavior was recorded for 60 minutes. One scratch episode was defined as lifting up either hind paw followed by scratching towards the pruritogen-injected or mechanically stimulated area from the time-point when the paw was lifted until it was placed back on the
